The effectiveness and safety of mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines among individuals with chronic kidney diseases

[Figure: see text]

Detalles Bibliográficos
Autores principales: Cheng, Franco Wing Tak, Fan, Min, Wong, Carlos King Ho, Chui, Celine Sze Ling, Lai, Francisco Tsz Tsun, Li, Xue, Wan, Eric Yuk Fai, Tang, Sydney Chi Wai, Chan, Esther Wai Yin, Wong, Ian Chi Kei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier, Inc., on behalf of the International Society of Nephrology. 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367175/
https://www.ncbi.nlm.nih.gov/pubmed/35964798
http://dx.doi.org/10.1016/j.kint.2022.07.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367175/
https://www.ncbi.nlm.nih.gov/pubmed/35964798
http://dx.doi.org/10.1016/j.kint.2022.07.018

Ejemplares similares